top of page
Dark-Background

The Future of Biologics Is Here.

See the difference.
Discover the potential of true clinical-grade biologics. 

VISION

Revolutionizing the World of Regenerative Medicine.

VEA was founded to provide transparent access to clinical-grade biologics internationally. As we grow into new markets, we strive to provide leading therapeutics for patients across the globe.

OUR PRODUCTS

Fully Isolated, Uncompromisingly Viable.

OPTIMIZED CELL VIABILITY

5 Million 

Isolated MSCs / ML

99%

Post Thaw Viability

VEA's STEM is our class leading biologic boasting up to 10 million isolated MSCs per mL. This product is validated through third party testing and is proven to have over 99% post thaw viability.

EXOSOMES

23 Billion

Isolated MSC Exosomes / ml

5ml

Vial Size

VEA X is a leading isolated exosome product derived from healthy, viable MSCs. This allows the practitioner to ensure signaling health and regenerative outcomes when applying this product. 

ADVANCED WHARTON'S JELLY

23

Billion Added Exosomes

1ml

Vial Size

WJ-X is a live-cell Wharton’s Jelly based product that retains all the natural characteristics of the structural extracellular matrix (ECM) and is enhanced with added isolated MSC-Exosomes (VEA-X).

WHY VEA

A New Method of Manufacturing

Our CSO has achieved recognition for his research in the production of clinical-grade human ASC. He holds a PhD in Biomedical Sciences from The Universidad Nacional de Colombia. This allows us to provide viable cellular products, directly to your door.

Image by CDC

evelopment of a technology for the production of Clinical Grade human ASC.

bottom of page